Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EPHA4 modulators(EPH receptor A4 modulators) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 01 Nov 2024 | |
Amyotrophic Lateral Sclerosis | Preclinical | US | 01 Nov 2024 | |
Frontotemporal Dementia | Preclinical | US | 01 Nov 2024 |